AGEN vs XLU
Agenus Inc (AGEN) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
XLU (XLU) common stock.
Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
XLU does not have a complete income-statement cache yet.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. XLU currently screens at market cap $0.
Not investment advice. Open the AGEN and XLU stock pages for the full models.
Not investment advice.